Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

Zwitterions sound like a distant cousin of Twitter (X), but in fact they are a common macromolecule found in human cells.

Zwitterions sound likes a distant cousin of Twitter (X), but in fact they are a common macromolecule found in human cells. Scientists at the University of Sydney are also now using Zwitterions to ...

Researchers combined animal models, human brain tissue, and molecular analysis to uncover a connection between Alzheimer's ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against other best drug stocks to buy now. Is ...

banking on improved demand for its products and services used in developing therapies. However, some life sciences firms such as Danaher (DHR.N), opens new tab have indicated smaller biotech ...

Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences.

The race to increase human life span through biotech just got tighter ... has just announced it's in the process of a $1 billion round of funding toward that goal. It will back clinical trials ...

Or discount its dominant position in a growing market, like Illumina. In any case, investors in undervalued biotech stock will need to do a few things: Patient and long-term-focused, as most ...

During a panel discussion at this year’s Fierce JPM Week—which took place alongside the annual J.P. Morgan Healthcare Conference in San Francisco—industry experts broke down what it takes to ...